PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.

PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer. 2010 Apr 01; 126(7):1630-9.

View in: PubMed

subject areas

Adaptor Proteins, Signal Transducing
Aged
Antigens, CD
Apoptosis Regulatory Proteins
Cadherins
Calcium-Calmodulin-Dependent Protein Kinases
Carcinoma, Non-Small-Cell Lung
Case-Control Studies
CpG Islands
Cyclin-Dependent Kinase Inhibitor p16
Death-Associated Protein Kinases
DNA Methylation
DNA Modification Methylases
DNA Repair Enzymes
Female
Follow-Up Studies
Humans
Immunoenzyme Techniques
In Situ Hybridization, Fluorescence
Lung
Lung Neoplasms
Male
Middle Aged
Monomeric GTP-Binding Proteins
Neoplasm Proteins
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Promoter Regions, Genetic
PTEN Phosphohydrolase
Survival Rate
Treatment Outcome
Tumor Suppressor Proteins

authors with profiles

Michael Liptay
Mary Fidler